Balancing Harm Reduction with the Safety of Public Spaces

Michelle Wu delivering her 2025 State of the City address. Courtesy of WikiMedia Commons.

In June 2024, Mayor Michelle Wu’s administration terminated the Community Syringe Redemption Program (CSRP). The CSRP, initiated in December 2020, incentivised the proper disposal of used needles. Under the program, drug users were compensated for each needle they properly disposed of. This encouraged safe discarding and kept needles off the streets. Since the program ended, reports of needle sightings throughout the city have raised concerns about public sanitation and safety. 

Later, in June 2026, Mayor Wu announced a plan to help reduce the fatal effects of drug use. Under the joint initiative, Wu and the Boston Public Health Commission announced four vending machines across the city carrying naloxone, commonly known by the brand name Narcan, sanitized needles for injection, and fentanyl test strips. Additionally, eight kiosks carrying naloxone were planned for areas with higher rates of overdose. 

This policy reflects a broader public health strategy known as harm reduction, which seeks to reduce the health risks associated with substance use. The Centers for Disease Control and Prevention explains that syringe service programs can reduce the transmission of HIV and hepatitis by providing sterilized equipment and safe disposal services. However, this rationale for distributing supplies is separate from how the city manages discarded syringes in public spaces. 

Despite the public health rationale, the initiative and broader changes to the city’s syringe policies have prompted concerns among some residents. Needles have reportedly been found in Back Bay, particularly around areas frequented by families. A needle was reportedly found in the lobby of a luxury apartment building, as well as inside the Boston Public Library, and open drug use has also been reported. Some citizens have attributed these concerns to Wu’s drug policies, arguing that making injection supplies more accessible may contribute to the visibility of drug use. Establishing whether the vending machines themselves have contributed to an increase in discarded needles, however, requires additional evidence. 

The scale of the issue can also be examined through data. Boston recorded 10,736 syringe-related complaints through its 311 system in 2024, with complaints reportedly increasing in 2025. These figures represent reports made through the city’s complaint system, rather than the total number of needles found or collected. However, complaint totals alone cannot establish whether the increase resulted from the termination of the CSRP, the introduction of syringe services, or other factors. 

Needle sightings have also been reported in Copley Square, a city landmark. Concerns have also emerged about the effects on business and tourism. Businesses in areas affected by visible drug use or improperly discarded syringes may face additional cleaning responsibilities and concerns about the experience of customers and visitors. Public spaces such as Copley Square and the Boston Public Library also serve residents who may have no involvement in drug use. At the same time, people who use drugs remain members of the community, and preventing overdoses and the spread of diseases can benefit the wider public. 

Boston’s syringe policies therefore raise a broader question about how cities should balance harm reduction with public-space upkeep. The challenge for Boston is to ensure that efforts to prevent overdose deaths are accompanied by measures to keep public spaces clean and safe.